Acute Treatment of Migraine Using the CEFALY Device

Exclusion Criteria

• •Pregnant women
• •Patients having received treatment with onabotulinum toxin (e.g., Botox, Dysport, Xeomin) to the head in the prior 4 months
• •Patients having received supraorbital nerve blocks in the prior 4 months
• •Diagnosis of other primary or secondary headache disorders, except of Medication Overuse Headache
• •Patients with only temporal or occipital headaches
• •Patients taking opioid medications
• •Patients having taken abortive migraine medication in the prior 3 hours
• •Allodynia: intolerance to supraorbital neurostimulation (allodynia) that makes the treatment not applicable (the patients will be excluded while the neurostimulation has already started).
• •Implanted metal or electrical devices in the head
• •Cardiac pacemaker or implanted or wearable defibrillator